Myeloproliferative Disorder

Haploidentical Allogeneic Peripheral Blood Transplantation: Examining Checkpoint Immune Regulators' Expression

MPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People With Myeloproliferative Neoplasms (MPNs)

Aprepitant Versus Hydroxyzine in Persistent Aquagenic Pruritus for Patients With Myeloproliferative Neoplasms

Cord Blood Transplant in Adults With Blood Cancers

Haplo Peripheral Blood Sct In GVHD Prevention

Fungal Prophylaxis With Isavuconazole for Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant (HCT)

Tocilizumab for the Prevention of Graft Versus Host Disease After Cord Blood Transplantation

Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.

Functional Characterization of Thrombopoietin/cMPL Receptor Mutations in Myeloproliferative Neoplasia

Total Body Irradiation +/- Total Lymphoid Irradiation & Anti-Thymocyte Globulin in Non-myeloablative Hematopoietic Cell Transplantation

Evaluation of Formin Gene Status and Expression in Myeloproliferative and Myelodysplastic Disorders

Allogeneic Hematopoietic Cell Transplantation From HLA-matched Donor After Flu-Mel-PTCy Versus Flu-Mel-ATG Reduced-intensity Conditioning

Preventing Stem Cell Transplant Complications With a Blood Separator Machine

The NUTRIENT Trial (NUTRitional Intervention Among myEloproliferative Neoplasms): Feasibility Phase

Clinical Characteristics of Aquagenic Pruritus in Patients With Myeloproliferative Neoplasms

Fludarabine Based Conditioning for Allogeneic Transplantation for Advanced Hematologic Malignancies

Low Dose IL-2, Hematopoietic Stem Cell Transplantation, IL2 for GVHD

Primary Thrombocythaemia 1 Trial

T-Cell Depleted Allogeneic Stem Cell Transplantation for Patients With Hematologic Malignancies

Nonmyeloablative Allogeneic Stem Cell Transplantation From HLA-Matched Unrelated Donor for the Treatment of Hematologic Disorders